A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
Cullgen (Shanghai),Inc
Cullgen (Shanghai),Inc
Bellicum Pharmaceuticals
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
University College, London
Dana-Farber Cancer Institute
University of Washington
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Yale University
Cellerant Therapeutics
M.D. Anderson Cancer Center
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
M.D. Anderson Cancer Center
Alaunos Therapeutics
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Healios K.K.
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey